Rhytec, Inc. Introduces New Skin Regeneration Technology

Portrait^® PSR3 Debuts at American Academy of Dermatology Meeting
February 17-21, 2005 in New Orleans

WALTHAM, MA February 18, 2005 - Rhytec, Inc. announces the introduction of Portrait^® PSR3, a breakthrough technology delivering true skin regeneration. Using millisecond pulses of Nitrogen plasma, the clinically proven Portrait^® PSR3 technology thermally modifies the skin’s architecture creating unique conditions for continuing regeneration and improvements in wrinkles, skin tone and texture, and surface discoloration. Clinical studies confirm an unparalleled range of effects with non-ablative rejuvenation and high-energy treatment of facial rhytides, as well as treatment of superficial skin lesions and actinic keratoses.

Portrait^® PSR3 is FDA-cleared for single-pass, low energy, repeat treatments and single-pass high energy treatment of facial rhytides and for the treatment of superficial skin lesions. Studies show regenerated reticular architecture of the upper dermis and a continuing regenerative process producing sustainable improvements in photodamage for up to a year following treatment. With Portrait^® PSR3 the epidermal layer remains intact immediately following treatment acting as a biological dressing and speeding healing. There is no evidence of scarring or hypopigmentation with single or multiple pass in clinical studies to date.

“Rhytec’s innovation in skin treatment is very exciting; the unique and advantageous healing profile following treatment with Portrait^® PSR3 does appear to have a truly revitalizing effect by regenerating the functional elements that make up our skin,” said Dr. Mark Goble, Chief Executive, Rhytec. With dramatic results and rapid healing, Portrait^® PSR3 addresses the unmet patient demand for visible improvement with minimal downtime.

Rhytec, Inc. launches the new Portrait^® PSR3 Technology for True Skin Regeneration at the 2005 American Academy of Dermatology Meeting in New Orleans, February 17 – 21.

About Rhytec
Rhytec develops innovative technologies based on sound scientific and clinical research for the dermatological, plastic and cosmetic surgery markets. Founded by Dr. Mark Goble in 2004, Rhytec is a spin-off of Gyrus Group PLC, an innovator in energy-based systems for the surgical market. Rhytec works with leading dermatologists to develop new technologies that enhance the skin’s appearance and function in order to improve the quality of life for patients seeking treatment. Rhytec, Inc. is based in Waltham, MA (US), Berkshire (UK), and Cardiff (UK). It is privately held.